The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patientsMatthew Kennedy, Mark S. Forman, Jared N. Cumming et al.|Science Translational Medicine|2016Cited by 416
A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson’s DiseaseMilton H. Werner, Aaron Ellenbogen, C. Warren Olanow et al.|Journal of Parkinson s Disease|2024Cited by 7